Aeon Respire's founders spent over 10 years studying and thinking about the roots of inflammatory and obstructive respiratory disease. Through this work they developed a deep appreciation for the importance of structural lung cells as both the instigators and mediators of airway narrowing in disease. This led to the prioritization of a new kind of target that's expressed in both the smooth muscle and the epithelium. They're now bringing their extensive expertise in this area to advance a better approach to achieve long-lasting and robust breathing health for millions.
Aeon Respire is building a strong supporting cast that represent the best in their field. We've sought the top thinkers in airway cell biology, medicinal chemistry, inhalation toxicology and respiratory clinical development. Our operational model is nimble with a deep field of noteworthy expertise.